Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease

American Journal of Gastroenterology

Volumn 106, Issue 9, 2011, Pages 1711-1717

  Zabron, Abigail A ^a   Horneffer Van Der Sluis, Verena M ^a,b   Wadsworth, Christopher A ^a   Laird, Fiona ^a   Gierula, Magdalena ^b   Thillainayagam, Andrew V ^c   Vlavianos, Panagiotis ^c   Westaby, David ^c   Taylor Robinson, Simon D ^a   Edwards, Robert J ^b   Khan, Shahid A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIPOCALIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; BILE; BILE ACID BLOOD LEVEL; BILIARY TRACT DISEASE; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PANCREAS DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERUM; URINALYSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BILE; BILIARY TRACT NEOPLASMS; CA-19-9 ANTIGEN; CHOLESTASIS; GALLSTONES; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; REGRESSION ANALYSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 80052473734     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.187     Document Type: Article

References (29)

1. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer. Nat Rev Gastroenterol Hepatol 2009; 6: 699-708.
2. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors and pathogenesis of cholangiocarcinoma. HPB 2008; 10: 77-82. (Pubitemid 351934989)
3. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-17.
4. Chakraborty S, Baine MJ, Sasson AR et al. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta 2011; 1815: 44-64.
5. Khan SA, Davidson BR, Goldin R et al. UK guidelines for the diagnosis and treatment of cholangiocarcinoma. Gut 2002; 51 (S6): VI1-9.
6. Khan SA, Thomas HC, Davidson BR et al. Cholangiocarcinoma. Lancet 2005; 366: 1303-14. (Pubitemid 41416587)
7. Greenhalf W, Grocock C, Harcus M et al. Screening of high-risk families for pancreatic cancer. Pancreatology 2009; 9: 215-22.
8. Farina A, Chambery A, Esposito S et al. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J Proteome Res 2009; 8: 159-69.
9. Björnsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999; 19: 501-8. (Pubitemid 30019064)
10. Farina A, Dumonceau JM, Lescuyer P. Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev Proteomics 2009; 6: 285-301.
11. Hanash AM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 2008; 452: 571-9. (Pubitemid 351483371)
12. Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr Opin Gastroenterol 2009; 25: 279-84.
13. Bonney GK, Craven RA, Prasad R et al. Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol 2008; 9: 149-58. (Pubitemid 351150126)
14. Bolignano D, Donato V, Lacquaniti A et al. Neutrophil gelatinaseassociated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 2010; 288: 10-6.
15. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10: 1045-56. (Pubitemid 35453824)
16. Goetz DH, Willie ST, Armen RS et al. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 2000; 39: 1935-41. (Pubitemid 30124000)
17. Laird F, Edwards RJ, Taylor-Robinson SD et al. Proteomic analysis of bile in benign and malignant pancreatobiliary disease. Gut 2009; 58 (SII): A1567.
18. Abdul-Salam VB, Wharton J, Cupitt J et al. Proteomic anaylsis of lung tissues from patients with pulmonary arterial hypertension. Circulation 2010; 122: 2058-67.
19. Fern á ndez CA, Yan L, Louis G et al. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 2005; 11: 5390-5. (Pubitemid 41060812)
20. Smith ER, Zurakowski D, Saad A et al. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 2008; 14: 2378-86. (Pubitemid 351551071)
21. Kubben FJ, Sier CF, Hawinkels LJ et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 2007; 43: 1869-76. (Pubitemid 47238246)
22. Zhang H, Xu L, Xiao D et al. Upregulation of neutrophil gelatinaseassociated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 2007; 60: 555-61. (Pubitemid 46867169)
23. Bauer M, Eickhoff JC, Gould MN et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 2008; 108: 389-97. (Pubitemid 351431077)
24. Furutani M, Arii S, Mizumoto o M et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 1998; 122: 209-14. (Pubitemid 28058638)
25. Han H, Bearss DJ, Browne LW et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002; 62: 2890-6. (Pubitemid 34525776)
26. Iacobuzio-Donahue CA, Maitra A, Olsen M et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003; 162: 1151-62. (Pubitemid 36350660)
27. Moniaux N, Chakraborty S, Yalniz M et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 2008; 98: 1540-7. (Pubitemid 351652327)
28. Nuntagowat C, Leelawat K, Tohtong R. NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation. Clin Exp Metastasis 2010; 27: 295-305.
29. Srisomsap C, Sawangareetrakul P, Subhasitanont P et al. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010; 2010: 437143.